Register for email alerts and news feeds:
This journal | BMJ Group
rss
Thorax 2005;60:981-983; doi:10.1136/thx.2005.045674
Copyright © 2005 BMJ Publishing Group Ltd & British Thoracic Society.

EDITORIAL

Improving survival in idiopathic PAH

Improving survival in idiopathic pulmonary arterial hypertension: revisiting the "kingdom of the near-dead"

S Mehta, G J Shoemaker

Southwest Ontario Pulmonary Hypertension Clinic, Divisions of Respirology and Cardiology, Departments of Medicine, London Health Sciences Center, and The Centre for Critical Illness Research, Lawson Health Research Institute, University of Western Ontario, London, Ontario Canada

Correspondence to:
Correspondence to:
Dr S Mehta
Division of Respirology, London Health Sciences Center - South Street Hospital, London, Ontario, Canada N6A 4G5; sanjay.mehta@lhsc.on.ca


Recent advances in the treatment of idiopathic PAH have resulted in increased survival

Keywords: pulmonary hypertension; survival analysis; epoprostenol; bosentan; endothelin

The first 150 words of the full text of this article appear below.

Idiopathic pulmonary arterial hypertension (PAH), formerly known as primary pulmonary hypertension, is characterised by raised pulmonary artery pressure and pulmonary vascular resistance in the absence of underlying significant cardiopulmonary or other medical disease. Idiopathic PAH is a progressive disorder that usually culminates in right ventricular failure and death. Moreover, patients with idiopathic PAH are often severely limited on exertion by dyspnoea and fatigue, and thus suffer from a poor quality of life.

Despite clinical recognition of idiopathic PAH for more than 100 years, there have been few effective therapeutic options until recently. Given the previous absence of effective pharmacological therapy, surgical removal of the disease by lung transplantation has been an important therapeutic option for patients with idiopathic PAH. Lung transplantation is associated with rapid and sustained improvement in pulmonary haemodynamics.1 Moreover, in individual patients with idiopathic PAH who do not respond to medical treatment, . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Chest Medicine Jobs

Chest Medicine Jobs